Even during the difficult period of COVID-19, when economic news around the world has been predominantly negative, Hungary has continuously announced new investments.
Minister of Foreign Affairs and Trade Péter Szijjártó emphasized that Hungary is one of the leaders in the fierce competition for investments, as companies are seeking ways to reorganize and become more efficient. And it’s a great sign that the country has been chosen by one of the world’s largest pharmaceutical companies as a new investment location.
Szijjártó said that the multinational company, which has had a strategic partnership with the government for seven years, is now establishing a center here for an activity in which Hungary is a leader in Central and Eastern Europe. Currently, 120 business service centers are operating in the country, employing more than 55,000 multilingual graduates.
Business service centers play a significant role in changing the dimension of the Hungarian economy, that is, moving it from being largely production-based to activities based on knowledge, with research and development elements, Szijjártó underlined.
There are currently 200 people working in Sanofi’s center, but it will have 350 employees by the end of 2022. Together with its new headquarters, Sanofi has five sites in Hungary, employing more than 2,000 people.